Cargando…

Hyperbaric oxygen therapy and chemokine administration - a combination with potential therapeutic value for treating diabetic wounds

Non-healing wounds impart serious medical problems to people with diabetes. Amongst 15% of diabetic patients, the incidence of foot ulcer is the most prevailing, which confers a significant risk of limb amputation, mainly due to hypoxia and impairment in cell signaling. Alteration in the expression...

Descripción completa

Detalles Bibliográficos
Autores principales: Venkataseshan, Jagannathan, Viswanathan, Pragasam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9791575/
https://www.ncbi.nlm.nih.gov/pubmed/36578873
http://dx.doi.org/10.4239/wjd.v13.i12.1122
_version_ 1784859437644644352
author Venkataseshan, Jagannathan
Viswanathan, Pragasam
author_facet Venkataseshan, Jagannathan
Viswanathan, Pragasam
author_sort Venkataseshan, Jagannathan
collection PubMed
description Non-healing wounds impart serious medical problems to people with diabetes. Amongst 15% of diabetic patients, the incidence of foot ulcer is the most prevailing, which confers a significant risk of limb amputation, mainly due to hypoxia and impairment in cell signaling. Alteration in the expression of chemokines and the related factors in diabetic conditions delays the recruitment of different cell types, including fibroblasts, keratinocytes, and immune cells such as macrophages to the site of injury, further impairing neovasculogenesis, re-epithelialization, and extracellular matrix formation. Thus, proper activation of effector cells through an accurate signal pathway is necessary for better therapeutic application. Hyperbaric oxygen therapy (HBOT) is the current treatment prescribed by medical practitioners, shown to have increased the wound healing rate by reducing the need for significant amputation among the diabetic population. However, the risk of morbidity associated with HBOT needs complete attention through rigorous research to avoid adverse outcomes. Altering the level of pro-angiogenic chemokines may regulate the inflammatory response, further promote vascularization, and enhance the complete healing of wounds in diabetic patients. Thus, a combination of better therapeutic approaches could pave the way for developing a successful treatment for diabetic foot and wound healing.
format Online
Article
Text
id pubmed-9791575
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Baishideng Publishing Group Inc
record_format MEDLINE/PubMed
spelling pubmed-97915752022-12-27 Hyperbaric oxygen therapy and chemokine administration - a combination with potential therapeutic value for treating diabetic wounds Venkataseshan, Jagannathan Viswanathan, Pragasam World J Diabetes Minireviews Non-healing wounds impart serious medical problems to people with diabetes. Amongst 15% of diabetic patients, the incidence of foot ulcer is the most prevailing, which confers a significant risk of limb amputation, mainly due to hypoxia and impairment in cell signaling. Alteration in the expression of chemokines and the related factors in diabetic conditions delays the recruitment of different cell types, including fibroblasts, keratinocytes, and immune cells such as macrophages to the site of injury, further impairing neovasculogenesis, re-epithelialization, and extracellular matrix formation. Thus, proper activation of effector cells through an accurate signal pathway is necessary for better therapeutic application. Hyperbaric oxygen therapy (HBOT) is the current treatment prescribed by medical practitioners, shown to have increased the wound healing rate by reducing the need for significant amputation among the diabetic population. However, the risk of morbidity associated with HBOT needs complete attention through rigorous research to avoid adverse outcomes. Altering the level of pro-angiogenic chemokines may regulate the inflammatory response, further promote vascularization, and enhance the complete healing of wounds in diabetic patients. Thus, a combination of better therapeutic approaches could pave the way for developing a successful treatment for diabetic foot and wound healing. Baishideng Publishing Group Inc 2022-12-15 2022-12-15 /pmc/articles/PMC9791575/ /pubmed/36578873 http://dx.doi.org/10.4239/wjd.v13.i12.1122 Text en ©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved. https://creativecommons.org/licenses/by-nc/4.0/This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial.
spellingShingle Minireviews
Venkataseshan, Jagannathan
Viswanathan, Pragasam
Hyperbaric oxygen therapy and chemokine administration - a combination with potential therapeutic value for treating diabetic wounds
title Hyperbaric oxygen therapy and chemokine administration - a combination with potential therapeutic value for treating diabetic wounds
title_full Hyperbaric oxygen therapy and chemokine administration - a combination with potential therapeutic value for treating diabetic wounds
title_fullStr Hyperbaric oxygen therapy and chemokine administration - a combination with potential therapeutic value for treating diabetic wounds
title_full_unstemmed Hyperbaric oxygen therapy and chemokine administration - a combination with potential therapeutic value for treating diabetic wounds
title_short Hyperbaric oxygen therapy and chemokine administration - a combination with potential therapeutic value for treating diabetic wounds
title_sort hyperbaric oxygen therapy and chemokine administration - a combination with potential therapeutic value for treating diabetic wounds
topic Minireviews
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9791575/
https://www.ncbi.nlm.nih.gov/pubmed/36578873
http://dx.doi.org/10.4239/wjd.v13.i12.1122
work_keys_str_mv AT venkataseshanjagannathan hyperbaricoxygentherapyandchemokineadministrationacombinationwithpotentialtherapeuticvaluefortreatingdiabeticwounds
AT viswanathanpragasam hyperbaricoxygentherapyandchemokineadministrationacombinationwithpotentialtherapeuticvaluefortreatingdiabeticwounds